Medication Description: Mifepristone (Mifepristone)
11- [4- (Dimethylamino) phenyl] -17-hydroxy-17- (1-propynyl) extra-4,9-dien-3-one.
Synonyms: Mifegin, Pencrofton, Mifegyne, Pencrofton.
Interferes with the binding of progesterone to the corresponding receptors.
Rapidly absorbed in the digestive tract, T Ѕ is 1 h.
Apply to abort uterine pregnancy in the early stages (up to 42 days).
Assign inside 0.6 g once. If after 2 weeks of miscarriage does not occur, produce a vacuum aspiration.
Possible side effects: uterine bleeding, discomfort and lower abdominal pain, weakness, headache, vomiting and nausea; contributes to the development of infectious diseases of the uterus and urogenital system.
The drug is contraindicated in pregnancy, exceeding 42 days, adrenal insufficiency, impaired hemostasis, anemia.
Apply only in a hospital.
Product form: tablets of 0.2 g (N. 3, 30).